Vida Ventures II, LLC 13D/13G Filings for Dyne Therapeutics, Inc. (DYN)

Vida Ventures II, LLC 13D and 13G filings for Dyne Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-10
4:31 pm
Sale		 2022-08-15 13D Dyne Therapeutics, Inc.
DYN		 Vida Ventures II, LLC 2,220,034
4.300%		 -740,012decrease
(-25.00%)		 Filing
2020-10-01
4:41 pm
Purchase		 2020-09-21 13D Dyne Therapeutics, Inc.
DYN		 Vida Ventures II, LLC 2,960,046
6.500%		 2,960,046increase
(New Position)		 Filing